Trial intelligence / Profile preview

Omega-3 Fatty Acids for Esophageal Inflammation in Barrett's Esophagus

NCT01733147Phase 4Completed

Sponsor
Mayo Clinic
Start
Nov 2012
Primary completion
Sep 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of omega-3-acid triglycerides in Barrett's esophagus, sponsored by Mayo Clinic. Started Nov 2012; status: completed.

02

Drugs

omega-3-acid triglycerides
03

Conditions

Barrett's esophagus

Beyond the preview

Go deeper on NCT01733147.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01733147.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call